SANOFI (SNW.DE) Fundamental Analysis & Valuation

FRA:SNW • FR0000120578

76.08 EUR
-0.26 (-0.34%)
Last: Mar 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SNW.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SNW. SNW was compared to 54 industry peers in the Pharmaceuticals industry. SNW has only an average score on both its financial health and profitability. SNW has a correct valuation and a medium growth rate. SNW also has an excellent dividend rating. With these ratings, SNW could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. SNW.DE Profitability Analysis

1.1 Basic Checks

  • In the past year SNW was profitable.
  • In the past year SNW had a positive cash flow from operations.
  • In the past 5 years SNW has always been profitable.
  • Each year in the past 5 years SNW had a positive operating cash flow.
SNW.DE Yearly Net Income VS EBIT VS OCF VS FCFSNW.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SNW has a Return On Assets of 9.85%. This is in the better half of the industry: SNW outperforms 68.52% of its industry peers.
  • Looking at the Return On Equity, with a value of 17.49%, SNW is in line with its industry, outperforming 59.26% of the companies in the same industry.
  • The Return On Invested Capital of SNW (13.76%) is better than 62.96% of its industry peers.
  • SNW had an Average Return On Invested Capital over the past 3 years of 7.41%. This is significantly below the industry average of 14.78%.
  • The 3 year average ROIC (7.41%) for SNW is below the current ROIC(13.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROIC 13.76%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SNW.DE Yearly ROA, ROE, ROICSNW.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of SNW (17.71%) is better than 70.37% of its industry peers.
  • In the last couple of years the Profit Margin of SNW has declined.
  • With a Operating Margin value of 23.28%, SNW perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SNW has grown nicely.
  • SNW has a Gross Margin (72.55%) which is in line with its industry peers.
  • SNW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SNW.DE Yearly Profit, Operating, Gross MarginsSNW.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SNW.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SNW is still creating some value.
  • The number of shares outstanding for SNW has been reduced compared to 1 year ago.
  • The number of shares outstanding for SNW has been reduced compared to 5 years ago.
  • Compared to 1 year ago, SNW has a worse debt to assets ratio.
SNW.DE Yearly Shares OutstandingSNW.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SNW.DE Yearly Total Debt VS Total AssetsSNW.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SNW has a debt to FCF ratio of 1.86. This is a very positive value and a sign of high solvency as it would only need 1.86 years to pay back of all of its debts.
  • SNW's Debt to FCF ratio of 1.86 is amongst the best of the industry. SNW outperforms 81.48% of its industry peers.
  • SNW has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • SNW has a better Debt to Equity ratio (0.22) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Altman-Z N/A
ROIC/WACC1.73
WACC7.94%
SNW.DE Yearly LT Debt VS Equity VS FCFSNW.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that SNW should not have too much problems paying its short term obligations.
  • SNW has a worse Current ratio (1.09) than 74.07% of its industry peers.
  • SNW has a Quick Ratio of 1.09. This is a normal value and indicates that SNW is financially healthy and should not expect problems in meeting its short term obligations.
  • SNW's Quick ratio of 1.09 is in line compared to the rest of the industry. SNW outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SNW.DE Yearly Current Assets VS Current LiabilitesSNW.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SNW.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.82% over the past year.
  • Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 5.58% on average per year.
  • The Revenue has been growing slightly by 5.29% in the past year.
  • The Revenue has been growing slightly by 4.57% on average over the past years.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • SNW is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.49% yearly.
  • SNW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.29% yearly.
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue Next Year6.58%
Revenue Next 2Y6.19%
Revenue Next 3Y5.8%
Revenue Next 5Y5.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SNW.DE Yearly Revenue VS EstimatesSNW.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SNW.DE Yearly EPS VS EstimatesSNW.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. SNW.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.73 indicates a reasonable valuation of SNW.
  • Based on the Price/Earnings ratio, SNW is valued cheaper than 87.04% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.15. SNW is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 8.97, the valuation of SNW can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, SNW is valued cheaper than 88.89% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.27. SNW is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.73
Fwd PE 8.97
SNW.DE Price Earnings VS Forward Price EarningsSNW.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, SNW is valued a bit cheaper than 70.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.83
EV/EBITDA N/A
SNW.DE Per share dataSNW.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • SNW's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of SNW may justify a higher PE ratio.
PEG (NY)1.16
PEG (5Y)1.74
EPS Next 2Y6.95%
EPS Next 3Y8.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SNW.DE Dividend Analysis

5.1 Amount

  • SNW has a Yearly Dividend Yield of 5.30%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.91, SNW pays a better dividend. On top of this SNW pays more dividend than 88.89% of the companies listed in the same industry.
  • SNW's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 5.3%

5.2 History

  • The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SNW.DE Yearly Dividends per shareSNW.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • The dividend of SNW is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y6.95%
EPS Next 3Y8.43%
SNW.DE Yearly Income VS Free CF VS DividendSNW.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

SNW.DE Fundamentals: All Metrics, Ratios and Statistics

SANOFI

FRA:SNW (3/11/2026, 7:00:00 PM)

76.08

-0.26 (-0.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.23%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap183.75B
Revenue(TTM)70.49B
Net Income(TTM)12.49B
Analysts76
Price Target98.4 (29.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.3%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DPN/A
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.22%
Min EPS beat(2)4.58%
Max EPS beat(2)5.86%
EPS beat(4)3
Avg EPS beat(4)3.54%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)6
Avg EPS beat(8)4.07%
EPS beat(12)8
Avg EPS beat(12)3.12%
EPS beat(16)11
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.93%
Revenue beat(16)7
Avg Revenue beat(16)14.42%
PT rev (1m)-2.07%
PT rev (3m)-8.39%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)5.74%
EPS NY rev (1m)0.29%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)-0.6%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 9.73
Fwd PE 8.97
P/S 2.61
P/FCF 16.83
P/OCF 16.83
P/B 2.57
P/tB 48.17
EV/EBITDA N/A
EPS(TTM)7.82
EY10.28%
EPS(NY)8.48
Fwd EY11.14%
FCF(TTM)4.52
FCFY5.94%
OCF(TTM)4.52
OCFY5.94%
SpS29.19
BVpS29.55
TBVpS1.58
PEG (NY)1.16
PEG (5Y)1.74
Graham Number72.11
Profitability
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROCE 16.67%
ROIC 13.76%
ROICexc 14.92%
ROICexgc 58.3%
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
FCFM 15.49%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 87.43%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z N/A
F-Score5
WACC7.94%
ROIC/WACC1.73
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.58%
Revenue Next 2Y6.19%
Revenue Next 3Y5.8%
Revenue Next 5Y5.29%
EBIT growth 1Y7.73%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.69%
EBIT Next 3Y14.49%
EBIT Next 5Y9.74%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SNW.DE FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SNW.DE.


What is the valuation status of SANOFI (SNW.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.


How profitable is SANOFI (SNW.DE) stock?

SANOFI (SNW.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for SNW stock?

The financial health rating of SANOFI (SNW.DE) is 5 / 10.


What is the earnings growth outlook for SANOFI?

The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 8.41% in the next year.